NCT05848466 2026-03-30Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors PatientsBio-Thera SolutionsPhase 1 Completed23 enrolled
NCT04381650 2025-12-10A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Completed161 enrolled 44 charts